ScreenerHero

CNTN Canton Strategic Holdings, Inc.

NAS · US · Healthcare · Biotechnology · cantonstrategic.com
2.260USD-3.42%Mkt Cap: 180.08M $P/E: —

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-tech…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap180.08M USD
Enterprise Value149.21M USD
Revenue (TTM)1.50M USD
Gross Profit1.50M USD
Net Income (TTM)-35.92M USD
Revenue/Share0.02 USD
Last Price2.260 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue99.75
P/S124.65
P/B0.40
EPS (TTM)-0.10
EPS (Forward)—
52W Range
1.75010% of range6.890
52W High6.890 USD
52W Low1.750 USD
Profitability
Gross Margin100.00%
Oper. Margin-80.36%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-9.03%
ROA-6.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.13M USD
CapEx (TTM)77.57M USD
FCF Margin-85.15%
FCF Yield-0.71%
Net Debt-37.24M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio15.70
Quick Ratio14.18
Book Value/Sh5.89 USD
Cash/Share0.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateMay 28, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.79.68M
Float71.09M
Insiders13.92%
Institutions25.20%
Short Interest
Short Ratio10.6d
Short % Float8.61%
Short % Out.8.50%
Shares Short6.78M
Short (prev mo.)7.82M
Technical
SMA 502.150 (+5.1%)
SMA 2003.050 (-25.9%)
Beta1.48
S&P 52W Chg16.45%
Avg Vol (30d)802.30K
Avg Vol (10d)764.05K
Technical Indicators
RSI (14)49.2
MACD0.0351
MACD Signal0.0486
MACD Hist.-0.0135
BB Upper2.616 USD
BB Middle2.298 USD
BB Lower1.981 USD
BB Width27.64%
ATR (14)0.1873 USD
Vol Ratio (20d)0.82x